US 10596216
Use of a Withania extract for the treatment of amyloid-related diseases
granted A61KA61K2236/19A61K2236/39
Quick answer
US patent 10596216 (Use of a Withania extract for the treatment of amyloid-related diseases) held by Ethnodyne and Centre National de la Recherche Scientifique (CNRS) expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ethnodyne and Centre National de la Recherche Scientifique (CNRS)
- Grant date
- Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2236/19, A61K2236/39, A61K36/068, A61K36/185